Lok AS[Author] - Search Results

Year	Number of Results
1981	1
1982	2
1983	4
1984	5
1985	11
1986	8
1987	8
1988	6
1989	10
1990	6
1991	11
1992	12
1993	11
1994	7
1995	8
1996	6
1997	6
1998	3
1999	3
2000	8
2001	8
2002	17
2003	11
2004	16
2005	16
2006	18
2007	23
2008	23
2009	30
2010	23
2011	27
2012	20
2013	19
2014	21
2015	20
2016	25
2017	33
2018	29
2019	29
2020	34
2021	40
2022	31
2023	13

1

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Terrault NA, et al. Among authors: lok asf. Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800. Hepatology. 2018. PMID: 29405329 Free PMC article. No abstract available.

2

SARS-CoV-2 vaccines: a triumph of science and collaboration.

Golob JL, Lugogo N, Lauring AS, Lok AS. Golob JL, et al. Among authors: lok as. JCI Insight. 2021 May 10;6(9):e149187. doi: 10.1172/jci.insight.149187. JCI Insight. 2021. PMID: 33822773 Free PMC article. Review.

3

How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?

Wong GLH, Gane E, Lok ASF. Wong GLH, et al. Among authors: lok asf. J Hepatol. 2022 Jun;76(6):1249-1262. doi: 10.1016/j.jhep.2021.11.024. J Hepatol. 2022. PMID: 35589248 Review.

4

Microbiome therapeutics for hepatic encephalopathy.

Bloom PP, Tapper EB, Young VB, Lok AS. Bloom PP, et al. Among authors: lok as. J Hepatol. 2021 Dec;75(6):1452-1464. doi: 10.1016/j.jhep.2021.08.004. Epub 2021 Aug 25. J Hepatol. 2021. PMID: 34453966 Review.

5

Update of the statements on biology and clinical impact of occult hepatitis B virus infection.

Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS; Taormina Workshop on Occult HBV Infection Faculty Members. Raimondo G, et al. Among authors: lok as. J Hepatol. 2019 Aug;71(2):397-408. doi: 10.1016/j.jhep.2019.03.034. Epub 2019 Apr 18. J Hepatol. 2019. PMID: 31004683 Free article. Review.

6

Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.

Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA, Singh S, Mohamed EA, Abu Dabrh AM, Prokop LJ, Wang Z, Murad MH, Mohammed K. Lok AS, et al. Hepatology. 2016 Jan;63(1):284-306. doi: 10.1002/hep.28280. Epub 2015 Nov 13. Hepatology. 2016. PMID: 26566246 Free article. Review.

7

Reply.

Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. Ghany MG, et al. Among authors: lok asf. Hepatology. 2022 Mar;75(3):761-763. doi: 10.1002/hep.32251. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34800047 No abstract available.

8

Reply.

Feld JJ, King WC, Lok AS. Feld JJ, et al. Among authors: lok as. Clin Gastroenterol Hepatol. 2022 Nov 11:S1542-3565(22)01051-5. doi: 10.1016/j.cgh.2022.10.036. Online ahead of print. Clin Gastroenterol Hepatol. 2022. PMID: 36372369 No abstract available.

9

Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice.

Zhang Z, Zhong X, Shen H, Sheng L, Liangpunsakul S, Lok AS, Omary MB, Wang S, Rui L. Zhang Z, et al. Among authors: lok as. Nat Commun. 2022 Aug 30;13(1):5111. doi: 10.1038/s41467-022-32575-8. Nat Commun. 2022. PMID: 36042192 Free PMC article.

10

Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion.

Papatheodoridis GV, Lekakis V, Voulgaris T, Lampertico P, Berg T, Chan HLY, Kao JH, Terrault N, Lok AS, Reddy KR. Papatheodoridis GV, et al. Among authors: lok as. J Hepatol. 2022 Dec;77(6):1670-1689. doi: 10.1016/j.jhep.2022.07.003. Epub 2022 Jul 16. J Hepatol. 2022. PMID: 35850281 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results